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Abstract: Traumatic brain injury (TBI) is a major cause of disability (1, 2). Sleep 
disturbances, such as insomnia, are very common following traumatic brain injury and 
have been reported in frequencies from 40% (3) to as high as 84% (4). Sleep disruption can 
be related to the TBI itself but may also be secondary to neuropsychiatric (e.g., depression) 
or neuromuscular (e.g., pain) conditions associated with TBI or to the pharmacological 
management of the injury and its consequences. Post-TBI insomnia has been associated 
with numerous negative outcomes including daytime fatigue, tiredness, difficulty 
functioning: impaired performance at work, memory problems, mood problems, greater 
functional disability, reduced participation in activities of daily living, less social and 
recreational activity, less employment potential, increased caregiver burden, greater sexual 
dysfunction, and also lower ratings of health, poor subjective wellbeing. These negative 
consequences can hamper the person’s reintegration into the community, adjustment after 
injury, and overall QOL. (5) The connection between depression and insomnia has not 
been investigated within the post TBI population to a great extent. For the general 
population, clinically significant insomnia is often associated with the presence of an 
emotional disorder (6). Fichtenberg et al. (2002) (7), in his study established that the 
strongest relationship with the diagnosis of insomnia belonged to depression. Given the 
high prevalence of depression during the first 2 years following TBI (8), a link between 
depression and insomnia among TBI patients makes innate sense. The present study aims 
at assessing role of sertralline in post TBI insomnia associated with depression. 
 
Introduction 
Traumatic brain injury (TBI) is a major 
cause of disability (1, 2). Sleep disturbances, 
such as insomnia, are very common following 
traumatic brain injury and have been reported 
in frequencies from 40% (3) to as high as 84% 
(4). Sleep disruption can be related to the TBI 
itself but may also be secondary to 
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neuropsychiatric (e.g., depression) or 
neuromuscular (e.g., pain) conditions 
associated with TBI or to the pharmacological 
management of the injury and its 
consequences. 
Post-TBI insomnia has been associated 
with numerous negative outcomes including 
daytime fatigue, tiredness, difficulty 
functioning: impaired performance at work, 
memory problems, mood problems, greater 
functional disability, reduced participation in 
activities of daily living, less social and 
recreational activity, less employment 
potential, increased caregiver burden, greater 
sexual dysfunction, and also lower ratings of 
health, poor subjective wellbeing. These 
negative consequences can hamper the 
person’s reintegration into the community, 
adjustment after injury, and overall QOL. (5) 
The connection between depression and 
insomnia has not been investigated within the 
post TBI population to a great extent. For the 
general population, clinically significant 
insomnia is often associated with the presence 
of an emotional disorder6. Fichtenberg et al. 
(2002) (7), in his study established that the 
strongest relationship with the diagnosis of 
insomnia belonged to depression. Given the 
high prevalence of depression during the first 
2 years following TBI (8), a link between 
depression and insomnia among TBI patients 
makes innate sense. 
The present study aims at assessing role of 
sertralline in post TBI insomnia associated 
with depression. 
Materials and methods 
The study was carried out   in 
Neurosurgery ward and OPD of SMS Medical 
College and group of hospitals, Rajasthan, a 
3000 bedded superspeciality tertiary care 
centre. Sample was recruited through the 
follow up in neurosurgery OPD and Indoor. 
Being the largest medical institute in the state 
of Rajasthan, it caters the health needs of entire 
state as well as neighboring states. 
A total of 250 male traumatic brain injury 
patients with mild to moderate severity were 
screened initially. Eighty patients were found 
to have depression on assessment with PHQ-9 
and subsequent interview with psychiatrist. 
Out of these eighty patients, fifty- six were 
found to have insomnia, who finally 
constituted the study sample size. The study 
was further divided randomly in to two 
groups, consisting of twenty eight patients in 
each group. One group designated as 
intervention group (cases) was given 50 mg 
sertralline daily PO. The other group was not 
given any medication and served as control 
group. 
 The nature and purpose of the study was 
explained to the participants and written 
informed consent was obtained either by the 
participant himself or his next of kin. The 
study was limited to male participants only to 
ensure the homogeneity of the group with 
regard to the interactions of demographic 
variables, disease characteristics, and social 
stresses. The study protocol was approved by 
the institution`s ethical committee. 
All the participants were evaluated initially 
after two week interval for first 4 weeks and at 
the end of 6 months.  
To be eligible to participate in study, the 
patients had to be  18 years or older, should 
have had at least two weeks old injury, have a 
  
 
 
 
Romanian Neurosurgery (2016) XXX 3 
 
 
 
 
 
 
 
history of TBI with a documented loss of 
consciousness or other evidence of a TBI (i.e., 
pathology on neuroimaging), and be able to 
comprehend or answer verbal or written 
questionnaires.  
Participants were excluded from the study 
if they were known 1. To have a serious 
medical illness, 2. To have a current substance 
abuse disorder using DSM-IV criteria, 3. To 
have mass brain lesions or other neurologic 
diagnoses other than TBI, 4. To have a history 
of current or past psychosis or mania, MDD or 
any other mental disorder except current 
depression using DSM-IV criteria, or 6. To 
have a history of clinically significant liver or 
renal disease. 
At the initial assessment, demographic 
characteristics of the cases and controls were 
assessed on a self-designed semi structured 
proforma by interviewing the participants 
with additional information on injury 
characteristics of the cases by exploring the 
medical records and neuroradiological 
investigations.  
Severity of TBI was assessed by GCS. 
Initially cases and controls were assessed on 
Insomnia Severity Scale for insomnia. 
At the end of six months, both cases and 
controls were assessed on ISI to measure 
improvement in sleep.  
Measures 
In this study, the interview was focused on 
assessment of severity of TBI, depression and 
insomnia using GCS, PHQ-9 and Insomnia 
severity scale (ISS). 
GCS (9), an extensively used clinical scale 
for assessing the depth and duration of 
impaired consciousness and coma. Three 
aspects of behavior are independently 
measured—motor responsiveness, verbal 
performance, and eye opening. These can be 
evaluated consistently by doctors and nurses 
and recorded on a simple chart which has 
proved practical both in a neurosurgical unit 
and in a general hospital. The scale facilitates 
consultations between general and special 
units in cases of recent brain damage, and is 
useful also in defining the duration of 
prolonged coma. 
Depression was assessed by administering 
the nine-item PHQ-9, a self-report version of 
PRIME-MD11 which assesses the presence of 
major depressive disorder using modified 
Diagnostic and Statistical Manual, Fourth 
edition (DSM-IV) criteria. There is good 
agreement reported between the PHQ 
diagnosis and those of independent psychiatry 
health professionals (for the diagnosis of any 
one or more PHQ disorder, kappa = 0.65; 
overall accuracy, 85%; sensitivity, 75%; 
specificity, 90%) (17, 18). In this study Hindi 
version of PHQ-9 was used. It has been 
validated in Indian population and is 
considered to be reliable tool for diagnosis of 
depression. The PHQ-9 is a dual instrument 
that is used to establish a provisional 
depressive disorder as well as it provides a 
symptoms severity score. For the diagnosis of 
depression, we define clinical significant 
depression as: a PHQ-9 score of 8–9 as minor 
depression, a PHQ-9 score of 10 or greater as 
moderate depression; a score of 15 or more 
and one of the two cardinal symptoms (either 
depressed mood or anhedonia) as definite 
major depression (10, 11). We considered 
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PHQ 9 score of 10 or more as depression in 
this study. 
Insomnia was assessed on Insomnia 
Severity Index (ISI) (12). ISI is one of the most 
commonly used disease-specific measures for 
self-perceived insomnia severity. 
The ISI has 7 items describing insomnia-
related health impairments. Each item is rated 
on a 5-point Likert scale with scores ranging 
from 0 to 4, indicting ‘‘none’’, ‘‘mild’’, 
‘‘moderate’’, ‘‘severe’’ and ‘‘very severe’’ sleep 
problems, respectively. The total ISI score is 
calculated by summing the scores from the 7 
items, and range from a minimum of 0 to a 
maximum of 28, with higher scores reflecting 
more severe sleep problems. In clinical 
assessments, the ISI total summary score falls 
into 1 of 4 ISI categories; with scores 0–7, 8–
14, 15–21, and 22–28 indicating no clinically 
significant insomnia, sub-threshold insomnia, 
moderate insomnia and, clinically severe 
insomnia, respectively. The psychometric 
properties of the ISI have been evaluated in 
earlier studies and have been reported to have 
sound measurement quality for measuring 
perceived insomnia severity and the impact of 
insomnia in different populations (13, 14). 
We used Hindi version of the Insomnia 
Severity Index (15) which has a reliability of 
0.91 and a corrected item correlation range of 
0.56–0.87. Hindi version of the Insomnia 
Severity Index is a valid and reliable tool for 
the measurement of severity of insomnia. 
Lesion localization was done on the basis of 
CT scan, conducted as part of the initial work 
up of the patient. The results were 
characterized as presence or absence of 
contusions, intracerebral bleed, subarachnoid, 
epidural or subdural bleed in various regions, 
namely, frontal, temporal, parietal and 
occipital.  
Statistical analysis 
Data were checked for normality, outliers, 
and missing data. No imputation of missing 
data was performed. Statistical analyses were 
performed by correlation analyses (Pearson 
and Spearman), paired t test and Chi-square 
tests analyses. 
Results 
A total of 250 male patients of TBI were 
recruited in this study. 35.6% of the 250 
patients were found to have depression 
(n=89). 9 out of 89 depressive patients 
dropped out from the study (10.11%). 80 
patients (32%) of TBI with depression were 
evaluated for insomnia. 56 patients (70%) of 
post TBI depression with insomnia finally 
constituted the study sample. 
Maximum number (30.4%) of patients 
with insomnia were found in the age group of 
18-24 years (n=17), followed by 26.7% in the 
age group 25-34 years (n=15). However it was 
found to be statistically insignificant 
(p=0.938). 
Insomnia as measured on ISI was 
statistically more common (p=0.04) in mild 
TBI cases (58.9%) than the moderate TBI 
(41.1%) patients with depression. Majority of 
the patients (46.43%) who had insomnia 
sustained injury more than 6 months back 
(n=26), followed by 23.2% of injury being less 
than 3 months duration (n=13). Although this 
observation was found to be statistically 
insignificant (p=0.934). 
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Neuroanatomical localization was also 
correlated with insomnia in post TBI 
depression among TBI patients. Left side of 
brain injury was present in the majority 
(55.35%) of patients. This was followed by 
right side injury in 39.28% of patients (n=22) 
and diffuse axonal injury in 5.35% of patients 
(n=3). It was found insignificant on statistical 
analysis (p=0.761) [Table 1].  
Cerebral contusion was the most common 
(32.14%) finding of injury (n=18), followed by 
multiple injury including contusion in 30.35% 
(n=17) of the cases. Out of these 17 cases, 14 
patients had contusion. Thus, overall patients 
with contusion constituted 57.14% (n=32) of 
the study sample. Other findings, like 
extradural, subdural, subarachnoid 
hemorrhage and even fractures were also 
found to be implicated in lesser frequency. We 
further tried to explore the distribution of 
cerebral contusion in these patients, and found 
14 (57.1%) among 32 contused patients had 
multiple contusions, although single lobe 
contusion were also associated with insomnia, 
but in lesser numbers [Table 2]. 
Mean score of ISI at the beginning of the 
treatment was 18.821 with SD 2.091 and 
18.643 with SD 3.129 in intervention and 
control group respectively, and this was found 
to be statistically insignificant (p=0.802). At 
the end of the study, significant improvement 
was observed in ISI scores in intervention 
group (mean=8.464, SD=2.202), as compared 
to control group (mean=10.786, 
SD=2.114).This effect was statistically 
significant (p=0.00018) [Table 3]. 
 
 
TABLE 1 
Demographic characteristics of TBI 
depressive insomniac patients 
age in years Cases Control Total  
18-24 10 7 17  
25-34 7 8 15 X2=0.798 
35-44 5 6 11 (p=0.938) 
45-54 4 5 9  
55-64 2 1 3  
65 or more 0 1 1  
type of injury     
RTA 22 24 46 X2=0.563 
FFH 4 3 7 (p=0.754) 
ASSAULT 2 1 3  
OTHERS 0 0 0  
     
GCS     
MILD 16 17 33 X2=0.074 
MODERATE 12 11 23 (p=0.786) 
     
DURATION OF 
HEAD INJURY 
    
<3 MONTHS 8 9 17 X2=0.136 
3-6 MTHS 7 6 13 (p=0.934) 
>6 MONTHS 13 13 26  
     
LOCALIZATION     
RIGHT SIDE 10 12 22 X2=0.547 
LEFT SIDE 16 15 31 (p=0.761) 
DIFFUSE AXONAL 
INJURY         
            2 1 3  
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TABLE 2 
Lesion type based on CT scan 
 
TABLE 3 
Statistical analysis of insomnia among TBI 
depressive patients 
  MEAN SD SE P value 
ISS (AT 0 
MTH) 
CASES 18.821 2.091 0.395 0.802 
 CONTROL 18.643 3.129 0.591  
ISS(AT 6 
MTH) 
CASES 8.464 2.202 0.416 0.00018 
 CONTROL 10.786 2.114 0.399  
 
Discussion 
Our study population was almost close to 
the age of distribution of TBI in general adult 
male population. The age range was 18-86 
years with a mean age of 31.83 years in the 
intervention group and 32.95 years in the 
control group. Jain et al. (2) and Verma et al. 
(2007) (16) have also reported similar findings 
with regard to age and sex distribution in their 
study on chronic TBI patients evaluated for 
sleep disorders.  
Insomnia was reported in 70% of post TBI 
depressive patients. This finding is supported 
by earlier studies, wherein insomnia has been 
reported between 15% and 77% in post TBI 
patients shortly after or well into the future (2-
4). This finding was considerably less than the 
77% reported by Varney et al. (16), who used 
DSM-III criteria. Conversely, these findings 
were considerably more than the 14% reported 
by Deb et al. (18) who relied on ICD-10 
diagnostic criteria. The correlation between 
occurrence of insomnia and duration in TBI 
was found insignificant. Insomnia has been 
reported between 29% and 50%% in post TBI 
patients during one year after the trauma (19, 
20, 21). Population-based studies indicate that 
insomnia occurs in approximately 40% of 
individuals with a TBI of any severity and is 
often the most prevalent somatic complaint in 
this population (27).  
Insomnia in depression was more common 
in mild TBI patients than those with moderate 
severity. The reason for this common 
occurrence in mild TBI could have been that 
mild TBI patients are more likely to retain 
their cognitive functions intact, thus are 
capable of acknowledging their deficits caused 
by trauma.  
Clinchot et al. (1998) (17) and Fichtenberg 
et al. (2002) (22) showed an inverse 
relationship and Cohen et al. (1992) (23) noted 
CT SCAN FINDINGS- Case Control Total 
contusion 8 10 18 
multiple injury 9 8 17 
EDH 1 3 4 
SDH 3 2 5 
SAH 2 0 2 
NAD/DAI 5 4 9 
OTHERS/FOREIGN BODY     0 1 1 
SITE OF CONTUSIONS IN 
BRAIN- 
   
RIGHT FRONTAL 1 2 3 
LEFT FRONTAL 2 2 4 
RIGHT PARIETAL 1 0 1 
LEFT PARIETAL 0 0 0 
RIGHT TEMPORAL 1 0 1 
LEFT TEMPORAL 1 2 3 
MULTIPLE CONTUSIONS       8 6 14 
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increased prevalence with increasing severity 
of TBI. Some researchers have postulated the 
reason for this paradoxical finding to the fact 
that the people with severe brain injury are 
likely to under report and those with milder 
injury are more aware of their problem and 
therefore more likely to report about 
insomnia. Verma et al. (2007) (16) looked at 
the more objective data that can be collected 
with polysomnography and multiple sleep 
latency test. Their work noted that there was a 
relationship between severity of TBI and some 
but not all of the measures of the sleep 
disorders. In particular more severe TBI was 
associated with higher percentage of stage I 
sleep, number of awakening per night and the 
night spent awake each night.  
This study has also tried to explore the 
neuroanatomical localization of injury in 
respect to insomnia. Cerebral contusion was 
the most commonly implicated area involving 
multiple lobes, however single lobe 
involvement was also seen. Brain injury 
secondarily caused by extradural, subdural or 
intraparenchymal hematoma or involvement 
of brainstem (with contusion, distortion and 
hemorrhage) can compromise 
neurotransmitter release. The raised intra-
cranial pressure during the acute or subacute 
stages of TBI, either secondarily to cerebral 
edema or cerebral hyperaemia may contribute 
indirectly (24). 
Our finding that sertraline is associated 
with decrease in insomnia symptoms after TBI 
is consistent with evidence about the 
neuropathological mechanism that may 
contribute to the development of major 
depression following TBI. Human post 
mortem pathologic (25), cerebrospinal fluid 
(26), and imaging (27) evidence supports a 
role for serotonin in the depressions of TBI 
patients. Patients who are depressed following 
mild TBI have blunted prolactin response to 
buspirone, suggesting altered serotonin 
function in these patients compared with 
patients not depressed after mild TBI. Hence, 
it may be argued that the occurrence of 
insomnia may have been associated with 
coexisting depression in these patients and 
improvement in mood symptoms with 
sertralline may have led to improvement in 
insomnia as well.  
Fava Maurizio et al (28), 2002, conducted a 
study to assess whether fluoxetine, sertraline, 
and paroxetine differ in efficacy and 
tolerability in depressed patients and the 
impact of baseline insomnia on outcomes. 
Patients (N = 284) with DSM-IV major 
depressive disorder were randomly assigned in 
a double-blind fashion to fluoxetine, 
paroxetine, or sertraline for 10 to 16 weeks of 
treatment. Using the Hamilton Rating Scale 
for Depression (HAM-D) sleep disturbance 
factor score, patients were categorized into low 
(<4) or high (≥4) baseline insomnia 
subgroups. Changes in depression and 
insomnia were assessed. Safety assessments 
included treatment-emergent adverse events 
(AEs), reasons for discontinuation, and AEs 
leading to discontinuation. In addition, AEs 
were evaluated within insomnia subgroups to 
determine emergence of activation or 
sedation. Depression improvement, assessed 
with the HAM-D-17 total score, was similar 
among treatments in all patients (p = 0.365) 
and the high (p = 0.853) and low insomnia (p 
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= 0.415) subgroups. Insomnia improvement, 
assessed with the HAM-D sleep disturbance 
factor score, was similar among treatments in 
all patients (p = 0.868) and in the high (p = 
0.852) and low insomnia (p = 0.982) 
subgroups. Analyses revealed no significant 
differences between treatments in the 
percentages of patients with substantial 
worsening, any worsening, worsening at 
endpoint, or improvement at endpoint in the 
HAM-D sleep disturbance factor in either 
insomnia subgroup. Treatments were well 
tolerated in most patients. No significant 
differences between treatments in the 
incidence of AEs suggestive of activation or 
sedation were seen in the insomnia subgroups. 
Improvement in overall depression and in 
associated insomnia was achieved by most 
patients regardless of baseline insomnia.  
Kathleen Brady et al (29), 2000, conducted 
a twelve-week, double-blind, placebo-
controlled trial preceded by a 2-week, single-
blind placebo lead-in period. Sertraline 
treatment yielded significantly greater 
improvement than placebo on 3 of the 4 
primary outcome measures including 
insomnia. Sertraline was well tolerated, with 
insomnia the only adverse effect reported 
significantly more often than placebo (16.0% 
vs 4.3%; P=.01). 
Since the ISI values also improved in 
controls over time although less than cases, it 
is possible that patients get adjusted over a 
period of time. Hence, it may be argued that 
the drug may not be as effective beyond initial 
few months after development of insomnia as 
in the beginning. However, it does not rule out 
the importance of intervention as compliance 
to treatment gets affected because of associated 
insomnia and depression.  
Conclusion 
There has been an understanding that the 
psychological consequences especially 
depression  are likely to affect insomnia 
independently, as it may also lead to poor 
participation in productive and healthy living, 
decreased social and leisure activities, reduced 
sexual interest, poor drug compliance further 
deteriorating the existing problem. The overall 
improvement in insomnia in these patients 
may be explained by the improvement in 
depression with sertraline treatment. 
Limitations 
The present study has not taken patients 
with severely low GCS into consideration. 
Moreover, ISI scale used is more of a subjective 
index which takes into consideration patient`s 
verbatum. 
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